Acologix Secures $24.3M in Series C Financing Round
Filed in archive Corporate and Industrial News on December 22, 2005
Yesterday, Acologix Inc., a privately held biopharmaceutical company, announced that it has raised $25.3 million in Series C financing, bringing its total raised fund to over $72 million.
Most of the funds will be used to put the company's drug candidate for uremic pruritus in dialysis patients into Phase III clinical trials. Pruritus refers to an unpleasant cutaneous sensation prompting about patients to scratch, and affects approximately 70% of dialysis patients.
In addition this drug candidate, Acologix will continue the development of the following lead compounds: AC-100, a hard tissue regeneration compound, and AC-200, a drug candidate aimed at reducing serum phosphate levels associated with Chronic kidney disease.
Source: Acologix
Tags: biotech venture financing acologix series series+financing financing+round acologix+secures
Vote for Acologix Secures $24.3M in Series C Financing Round:
|
Rating: 9.50 out of 4 vote(s) cast.
|
| RSS |  |
 | |
| Yahoo! |
|
| Addthis |
|
| Bloglines |
|
Most Popular
Best of
Biotech Hubs and Facilities
Biotech/Science Blogs
Corporate and Industrial News
Diagnostics, Methodologies and Instrumentation
Did you know
Drugs, Vaccines and Therapeutics
Energy, Environment and Ecology
Food and Agriculture
Gene Therapy
Genomics, Proteomics and Bioinformatics
Information About
Meetings and Other Events
Microbiology
Misc
Nanomedicine
Other Biotechnology News
Patents and Intellectual Property Rights
Quick introduction
Stem Cells